Cargando…
LGG-06. COMPREHENSIVE GENOMIC CHARACTERIZATION AND INTEGRATED CLINICAL ANALYSIS OF LOW-GRADE GLIOMAS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1
BACKGROUND: Low-grade gliomas (LGGs) arising in children with neurofibromatosis type 1 (NF1) are usually not biopsied. To identify secondary genetic alterations or molecular features that may contribute to pathogenesis and correlate with clinical behavior, we initiated a comprehensive molecular and...
Autores principales: | Fisher, Michael, Jones, David, Li, Yimei, Guo, Xiaofan, Sonawane, Poonam, Waanders, Angela, Phillips, Joanna, Weiss, William, Resnick, Adam, Gosline, Sara, Banerjee, Jineta, Guinney, Justin, Gnekow, Astrid, Kandels, Daniela, Foreman, Nicholas, Korshunov, Andrey, Ryzhova, Marina, Massimi, Luca, Gururangan, Sri, Kieran, Mark, Wang, Zhihong, Fouladi, Maryam, Sato, Mariko, Øra, Ingrid, Holm, Stefan, Markham, Stephen, Beck, Pengbo, Jäger, Natalie, Wittmann, Andrea, Sommerkamp, Alexander, Sahm, Felix, Pfister, Stefan, Gutmann, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168145/ http://dx.doi.org/10.1093/neuonc/noab090.130 |
Ejemplares similares
-
LGG-11. Analysis of neurosurgical complications in pediatric supratentorial midline low-grade glioma – results from the German LGG studies
por: Weiß, Sarah, et al.
Publicado: (2022) -
LGG-42. Thromboembolic toxicity observed with concurrent trametinib and lenalidomide therapy
por: Chan, Priya, et al.
Publicado: (2022) -
LGG-54. Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia
por: Chatterjee, Jit, et al.
Publicado: (2022) -
LGG-04. A PHASE II RE-TREATMENT STUDY OF SELUMETINIB FOR RECURRENT OR PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (pLGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY
por: Fangusaro, Jason, et al.
Publicado: (2020) -
LGG-27. TARGETED THERAPY FOR PEDIATRIC LOW-GRADE GLIOMAS AND PLEXIFORM NEUROFIBROMAS WITH TRAMETINIB
por: Nguyen, Tiffany, et al.
Publicado: (2020)